The two-drug regimen dolutegravir/lamivudine is as effective as the three-drug regimen dolutegravir plus tenofovir ...
BIC/TAF/FTC demonstrated a stronger long-term immunologic response than DTG/TDF/FTC in patients with HIV who had low CD4+ counts.
As a part of its life cycle, human immunodeficiency virus-1 (HIV-1) inserts a copy of its DNA into human immune cells. Some of these newly infected immune cells can then transition into a dormant, ...
Low CD4+ cell count, STI coinfection, new ART initiation, and patient race predicted mpox-related hospitalization among patients with HIV coinfection.
NAIROBI, KENYA: Kenya on Thursday witnessed the launch of a revolutionary test kit for CD4 cells taking the management of HIV/AIDS to a new level. Health experts need to know the status of CD4 cells ...
Toxoplasma gondii poses serious risks during pregnancy and to those with weakened immune systems, and Clinicians must ...
SEATTLE – MAY 24, 2023 – Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and other collaborating institutions have characterized robust T-cell ...
A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF ...
Swiss study shows 60% of migrant HIV diagnoses are made post-arrival, challenging assumptions about when infections actually ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback